Literature DB >> 20103863

High-resolution mapping of copy number aberrations and identification of target genes in hepatocellular carcinoma.

Yutaka Midorikawa1, Wei Tang, Yasuyuki Sugiyama.   

Abstract

Hepatocarcinogenesis involves complex combinations of molecular events, such as genetic aberrations, epigenetic changes, and alterations in gene expression. To elucidate the mechanism of hepatocarcinogenesis, it is necessary to reconstruct these molecular events at each level. This article presents a review of copy number analyses of hepatocellular carcinoma (HCC) using traditional comparative genomic hybridization (CGH), arraybased CGH (aCGH), and single nucleotide polymorphism (SNP) arrays. A number of studies have applied CGH technology for copy number analysis of HCC and have indicated the significance of correlations of frequent genomic aberrations with various clinicopathological parameters, prediction of recurrence and prognosis, and treatment selection, followed by comprehensive genomic analysis using aCGH with much higher resolution. Furthermore, we present our data regarding genomic aberrations of HCC obtained using the Genome Imbalance Map (GIM) algorithm, which simultaneously detects DNA copy number alterations and loss of heterozygosity using SNP arrays, and the Expression Imbalance Map (EIM) algorithm, which detects mRNA expression imbalance correlated with chromosomal regions. Using these two algorithms, we integrated the expression profiles, locus information, and genomic aberrations in a systematic manner, which is effective for detecting structural genomic abnormalities, such as chromosomal gains and losses, and showed that gene expression profiles are subject to chromosomal bias.

Entities:  

Mesh:

Year:  2007        PMID: 20103863

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  7 in total

1.  Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Zhang Zhao; Guang-Yong Chen; Jiang Long; Hai Li; Jian Huang
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

2.  Molecular pathology of hepatic neoplasms: classification and clinical significance.

Authors:  Zenta Walther; Dhanpat Jain
Journal:  Patholog Res Int       Date:  2011-04-07

3.  Improved Statistical Analysis for Array CGH-Based DNA Copy Number Aberrations.

Authors:  Hongmei Jiang; Zhong-Zheng Zhu; Yue Yu; Simon Lin; Lifang Hou
Journal:  Cancer Inform       Date:  2011-10-19

4.  Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.

Authors:  Juan Liu; Cen Zhang; Meihua Lin; Wei Zhu; Yingjian Liang; Xuehui Hong; Yuhan Zhao; Ken H Young; Wenwei Hu; Zhaohui Feng
Journal:  Oncotarget       Date:  2014-05-15

Review 5.  Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.

Authors:  Chang-Qing Yin; Chun-Hui Yuan; Zhen Qu; Qing Guan; Hao Chen; Fu-Bing Wang
Journal:  Dis Markers       Date:  2016-06-15       Impact factor: 3.434

6.  Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma.

Authors:  Chenhao Zhou; Wentao Zhang; Wanyong Chen; Yirui Yin; Manar Atyah; Shuang Liu; Lei Guo; Yi Shi; Qinghai Ye; Qiongzhu Dong; Ning Ren
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

7.  Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma.

Authors:  Xiuqing Dong; Geng Chen; Xinghui Huang; Zhenli Li; Fang Peng; Hengkai Chen; Yang Zhou; Lei He; Liman Qiu; Zhixiong Cai; Jingfeng Liu; Xiaolong Liu
Journal:  Mol Oncol       Date:  2022-01-10       Impact factor: 7.449

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.